Immunohistochemical assessment of parafibromin in mouse and human tissues

Journal of Anatomy

Volumn 209, Issue 6, 2006, Pages 817-827

  Porzionato, Andrea ^a   Macchi, Veronica ^a   Barzon, Luisa ^a   Masi, Giulia ^a   Iacobone, Maurizio ^a   Parenti, Anna ^a   Palù, Giorgio ^a   De Caro, Raffaele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

HRPT2; Human; Hyperparathytoidism; Immunohistochemistry; Parafibromin

Indexed keywords

PARAFIBROMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; COLON MUCOSA; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOPLASM; ENDOMETRIUM; ENDOTHELIUM; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS INTERMEDIATE LOBE; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY TUBULE; LIVER CELL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; SMOOTH MUSCLE; SPECIES COMPARISON; STOMACH GLAND; THYROID GLAND; TISSUE TYPES; UROTHELIUM;

ADULT; AGED; ANIMALS; CELL NUCLEUS; CELLS; CYTOPLASM; FEMALE; FIBROMA; GASTRIC MUCOSA; HEPATOCYTES; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; KIDNEY TUBULES; MALE; MICE; MIDDLE AGED; MUTATION; PITUITARY GLAND; SPECIES SPECIFICITY; SYNDROME; TUMOR SUPPRESSOR PROTEINS;

EID: 33751231456     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2006.00657.x     Document Type: Article

References (34)

1. Betz JL, Chang M, Washburn TM, Porter SE, Mueller CL, Jaehning JA (2002) Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism. Mol Genet Genomics 268, 272-285.
2. Bradley KJ, Hobbs MR, Buley ID, et al. (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257, 18-26.
3. Carpten JD, Robbins CM, Villablanca A, et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32, 676-680.
4. Cavaco BM, Barros L, Pannett AA, et al. (2001) The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. QJM 94, 213-222.
5. Hahn MA, Marsh DJ (2005) Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene 24, 6241-6248.
6. Hampsey M, Reinberg D (2003) Tails of intrigue: Phosphorylation of RNA polymerase II mediates histone methylation. Cell 113, 429-432.
7. Haven CJ, Wong FK, van Dam EW, et al. (2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85, 1449-1454.
8. Henderson BR, Eleftheriou A (2000) A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp Cell Res 256, 213-224.
9. Hobbs MR, Pole AR, Pidwirny GN, et al. (1999) Hyperparathyroidism-jaw tumor syndrome: The HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet 64, 518-525.
10. Huang TT, Miyamoto S (2001) Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol 21, 4737-4747.
11. Juhlin C, Larsson C, Yakoleva T, et al. (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13, 509-523.
12. Krogan NJ, Dover J, Wood A, et al. (2003) The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: Linking transcriptional elongation to histone methylation. Mol Cell 11, 721-729.
13. Mosimann C, Hausmann G, Basler K (2006) Parafibromin/Hyrax activates Wnt/ Wg target gene transcription by direct association with beta-catenin/ Armadillo. Cell 125, 327-341.
14. Mueller CL, Porter SE, Hoffman MG, Jaehning JA (2004) The Paf1 complex has functions independent of actively transcribing RNA polymerase II. Mol Cell 14, 447-456.
15. Ng HH, Dole S, Struhl K (2003a) The Rtf1 component of the Paf1 transcriptional elongation complex is required for ubiquitination of histone H2B. J Biol Chem 278, 33625-33628.
16. Ng HH, Robert F, Young RA, Struhl K (2003b) Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell 11, 709-719.
17. Pimenta FJ, Gontijo Silveira LF, Tavares GC, et al. (2006) HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 42, 735-739.
18. Pokholok DK, Hannett NM, Young RA (2002) Exchange of RNA polymerase II initiation and elongation factors during gene expression in vivo. Mol Cell 9, 799-809.
19. Porter SE, Washburn TM, Chang M, Jaehning JA (2002) The yeast pafl-rNA polymerase II complex is required for full expression of a subset of cell cycle-regulated genes. Eukaryot Cell 1, 830-842.
20. Porter SE, Penheiter KL, Jaehning JA (2005) Separation of the Saccharomyces cerevisiae Paf1 complex from RNA polymerase II results in changes in its subnuclear localization. Eukaryot Cell 4, 209-220.
21. Rondon AG, Gallardo M, Garcia-Rubio M, Aguilera A (2004) Molecular evidence indicating that the yeast PAF complex is required for transcription elongation. EMBO Rep 5, 47-53.
22. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, et al. (2005) The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25, 612-620.
23. Shi X, Chang M, Wolf AJ, et al. (1997) Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme. Mol Cell Biol 17, 1160-1169.
24. Squazzo SL, Costa PJ, Lindstrom DL, et al. (2002) The Paf1 complex physically and functionally associates with transcription elongation factors in vivo. EMBO J 21, 1764-1774.
25. Stolinski LA, Eisenmann DM, Arndt KM (1997) Identification of RTF1, a novel gene important for TATA site selection by TATA box-binding protein in Saccharomyces cerevisiae. Mol Cell Biol 17, 4490-4500.
26. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18, 1660-1672.
27. Szabo J, Heath B, Hill VM, et al. (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56, 944-950.
28. Tan MH, Morrison C, Wang P, et al. (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10, 6629-6637.
29. Tan MH, Teh BT (2004) Renal neoplasia in the hyperparathyroidism-jaw tumor syndrome. Curr Mol Med 4, 895-897.
30. Teh BT, Farnebo F, Kristoffersson U, et al. (1996) Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: Linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81, 4204-4211.
31. Teh BT, Farnebo F, Twigg S, et al. (1998) Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 83, 2114-2120.
32. Wood A, Schneider J, Dover J, Johnston M, Shilatifard A (2003) The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J Biol Chem 278, 34739-34742.
33. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24, 1272-1276.
34. Yart A, Gstaiger M, Wirbelauer C, et al. (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25, 5052-5060.